GA
DPLO

Geneva Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Geneva Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,635
Closed -$386K – 699
2015
Q2 		$386K Buy
+8,635
New +$325K 0.01% 478

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geneva Advisors's DPLO Position: Q3 2015 in Review

Geneva Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2015, closing a stake of 8,635 shares — an estimated $386K sold.

Geneva Advisors first reported a position in DPLO in Q2 2015 and held it in 1 quarter. The position peaked at $386K in Q2 2015. 130 funds tracked by Wall St. Rank hold DPLO as of Q3 2015.

  • Geneva Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2015 after selling out during the quarter.
  • Geneva Advisors sold 8,635 DIPLOMAT PHARMACY, INC. shares in Q3 2015, an estimated $386K.
  • Geneva Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 1 quarter.
  • Geneva Advisors's DIPLOMAT PHARMACY, INC. position peaked at $386K in Q2 2015.
  • 130 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2015.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.